Subscribe

David Boyer, MD

Articles by David Boyer, MD

David Boyer, MD, on Promising Efficacy of Suprachoroidal Gene Therapy in nAMD

David Boyer, MD, on Promising Efficacy of Suprachoroidal Gene Therapy in nAMD

ByDavid Boyer, MD

October 3rd 2023

The senior partner at Retina Vitreous Associates Medical Group discussed efficacy and safety data from the phase 2 AAVIATE trial.

David Boyer, MD, on Potential Advantages of Suprachoroidal Gene Therapy for Neovascular AMD

David Boyer, MD, on Potential Advantages of Suprachoroidal Gene Therapy for Neovascular AMD

ByDavid Boyer, MD

August 17th 2023

The senior partner at Retina Vitreous Associates Medical Group discussed new findings from the AAVIATE study of RGX-314.

Latest Updated Articles

Trending on CGTlive®

CGTLive®’s Weekly Rewind – October 24, 2025

© 2025 MJH Life Sciences^®

All rights reserved.